Darrin M. Beaupre's most recent trade in Ideaya Biosciences Inc was a trade of 175,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ideaya Biosciences Inc | Darrin M. Beaupre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | |
| Ideaya Biosciences Inc | Darrin M. Beaupre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 185,000 | 185,000 | - | - | Stock Option (right to buy) | |
| Ideaya Biosciences Inc | Darrin M. Beaupre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 160,000 | 160,000 | - | - | Stock Option (right to buy) | |
| Ideaya Biosciences Inc | Darrin M. Beaupre | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 90,000 | 90,000 | - | - | Stock Option (right to buy) |